As of 2025-04-19, the EV/EBITDA ratio of Twist Bioscience Corp (TWST) is -14.45. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Twist's latest enterprise value is 1,973.72 mil USD. Twist's TTM EBITDA according to its financial statements is -136.62 mil USD. Dividing these 2 quantities gives us the above Twist EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 13.4x | 12.2x |
| Forward P/E multiples | 14.0x - 15.1x | 14.5x |
| Fair Price | (28.26) - (26.89) | (26.86) |
| Upside | -176.8% - -173.1% | -173.0% |
| Date | EV/EBITDA |
| 2025-04-17 | -14.45 |
| 2025-04-16 | -15.17 |
| 2025-04-15 | -15.63 |
| 2025-04-14 | -15.77 |
| 2025-04-11 | -15.34 |
| 2025-04-10 | -14.37 |
| 2025-04-09 | -15.96 |
| 2025-04-08 | -13.74 |
| 2025-04-07 | -14.53 |
| 2025-04-04 | -14.18 |
| 2025-04-03 | -14.75 |
| 2025-04-02 | -15.06 |
| 2025-04-01 | -15.38 |
| 2025-03-31 | -15.52 |
| 2025-03-28 | -16.00 |
| 2025-03-27 | -16.53 |
| 2025-03-26 | -16.67 |
| 2025-03-25 | -17.70 |
| 2025-03-24 | -18.00 |
| 2025-03-21 | -17.11 |
| 2025-03-20 | -16.74 |
| 2025-03-19 | -16.59 |
| 2025-03-18 | -16.09 |
| 2025-03-17 | -16.87 |
| 2025-03-14 | -15.83 |
| 2025-03-13 | -15.46 |
| 2025-03-12 | -15.55 |
| 2025-03-11 | -15.46 |
| 2025-03-10 | -14.41 |
| 2025-03-07 | -15.60 |
| 2025-03-06 | -15.49 |
| 2025-03-05 | -16.74 |
| 2025-03-04 | -15.70 |
| 2025-03-03 | -14.58 |
| 2025-02-28 | -15.33 |
| 2025-02-27 | -15.22 |
| 2025-02-26 | -16.43 |
| 2025-02-25 | -16.20 |
| 2025-02-24 | -16.37 |
| 2025-02-21 | -16.42 |
| 2025-02-20 | -18.06 |
| 2025-02-19 | -19.33 |
| 2025-02-18 | -18.77 |
| 2025-02-14 | -19.16 |
| 2025-02-13 | -18.84 |
| 2025-02-12 | -18.19 |
| 2025-02-11 | -18.55 |
| 2025-02-10 | -19.61 |
| 2025-02-07 | -21.22 |
| 2025-02-06 | -21.83 |